Please login to the form below

Not currently logged in
Email:
Password:

Revinty Ellipta

This page shows the latest Revinty Ellipta news and features for those working in and with pharma, biotech and healthcare.

Boehringer/Lilly's empagliflozin among CHMP recommendations

Boehringer/Lilly's empagliflozin among CHMP recommendations

Other positive opinions issued by the CHMP included Actavis' Ebilfumin, a generic version of Roche's flu drug Tamiflu (oseltamivir), and GlaxoSmithKline's Revinty Ellipta (fluticasone furoate and vilanterol) for the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics